Skip to main navigation Skip to search Skip to main content

TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer

  • TUXEDO investigators

Research output: Contribution to journalArticlepeer-review

70 Downloads (Pure)

Search results